A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

Adjuvant Melanoma Stakeholder Treatment Preference Study

The purpose of this study is to understand the trade-offs that participants with surgically treated melanoma would be willing to make among key features and outcomes of adjuvant anti-cancer treatments or no adjuvant treatment / observation.

Inclusion Criteria:

• Self-reported medical diagnosis of stage II or stage III melanoma
• Have been resected (had surgery) for their melanoma within 12 months prior to study participation

Exclusion Criteria:

• Self-reported stage IIa
• Self-reported recurrence of melanoma after surgery

Other protocol-defined inclusion/exclusion criteria apply